Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics
Mankind Pharma enters into an agreement to acquire a majority stake in Belgium-based Armed Cell Therapeutics, which is developing next-generation CAR-T cancer therapies.
Innovative Treatments | 16/10/2026 | By News Bureau
JCR Pharmaceuticals secures its first international approval for Izcargo in the UAE, expanding access to its innovative blood-brain barrier-penetrating therapy for patients with Hunter syndrome and advancing rare disease treatment across the MENA region.
Innovative Treatments | 23/07/2026 | By News Bureau | 193
UK Accelerates Clinical Trials, Slashing Set-Up Time to Boost Patient Access
Government-backed reforms and Euro 137 million investment cut trial start times significantly, enabling faster access to innovative treatments through the National Health Service.
Innovative Treatments | 17/04/2026 | By News Bureau | 152
UK Halves Clinical Trial Approval Times Through Major Digital Reforms
Backed by major reforms and new digital platforms at the Medicines and Healthcare products Regulatory Agency (MHRA), the UK has reduced the average clinical trial approval time by more than half — from 91 days to just 41 days.
Innovative Treatments | 08/10/2025 | By Dineshwori | 342
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy